Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Gerosa

Showing results (61-70 of 120) with videos related to

Pageof 12
Sort By:
Autoimmunity Reviews|January 3, 2024
Deciphering the clinical significance of longitudinal antiphospholipid antibody titersCecilia B Chighizola, Rohan Willis, Gabriella Maioli, et al.
Vaccines|May 28, 2022
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort StudyMaria Gerosa, Tommaso Schioppo, Lorenza Maria Argolini, et al.
Annals of the Rheumatic Diseases|February 19, 2024
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohortIoannis Parodis, Julius Lindblom, Guillermo Barturen, et al.
The Journal of Rheumatology|June 3, 2017
Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter StudyMara Taraborelli, Rossella Reggia, Francesca Dall'Ara, et al.
Vaccines|July 30, 2025
Long Term Outcomes of Anti-COVID-19 Vaccines in Patients with Systemic Lupus Erythematosus: A Multicentre StudyGiovanni Benanti, Giuseppe A Ramirez, Tommaso Schioppo, et al.
Annals of the Rheumatic Diseases|June 21, 2020
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patientsLorenzo Beretta, Guillermo Barturen, Barbara Vigone, et al.
Clinical and Experimental Rheumatology|August 28, 2015
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre studyChiara Bazzani, Rossana Scrivo, Laura Andreoli, et al.
Clinical and Experimental Rheumatology|September 17, 2020
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study)Cecilia Beatrice Chighizola, Francesca Crisafulli, Ariela Hoxha, et al.
Rheumatology (Oxford, England)|June 13, 2026
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry studyIbrahim Tohidi-Esfahani, Veronica Venturelli, Maria Tektonidou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 27, 2023
Fluctuation of Anti-Domain 1 and Anti-β<sub>2</sub> -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid AntibodiesCecilia B Chighizola, Francesca Pregnolato, Danieli Andrade, et al.
Pageof 12

Showing results (61-70 of 120) with videos related to

Sort By:
Pageof 12
Autoimmunity Reviews|January 3, 2024
Deciphering the clinical significance of longitudinal antiphospholipid antibody titersCecilia B Chighizola, Rohan Willis, Gabriella Maioli, et al.
Vaccines|May 28, 2022
The Impact of Anti-SARS-CoV-2 Vaccine in Patients with Systemic Lupus Erythematosus: A Multicentre Cohort StudyMaria Gerosa, Tommaso Schioppo, Lorenza Maria Argolini, et al.
Annals of the Rheumatic Diseases|February 19, 2024
Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohortIoannis Parodis, Julius Lindblom, Guillermo Barturen, et al.
The Journal of Rheumatology|June 3, 2017
Longterm Outcome of Patients with Primary Antiphospholipid Syndrome: A Retrospective Multicenter StudyMara Taraborelli, Rossella Reggia, Francesca Dall'Ara, et al.
Vaccines|July 30, 2025
Long Term Outcomes of Anti-COVID-19 Vaccines in Patients with Systemic Lupus Erythematosus: A Multicentre StudyGiovanni Benanti, Giuseppe A Ramirez, Tommaso Schioppo, et al.
Annals of the Rheumatic Diseases|June 21, 2020
Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patientsLorenzo Beretta, Guillermo Barturen, Barbara Vigone, et al.
Clinical and Experimental Rheumatology|August 28, 2015
Prospectively-followed pregnancies in patients with inflammatory arthritis taking biological drugs: an Italian multicentre studyChiara Bazzani, Rossana Scrivo, Laura Andreoli, et al.
Clinical and Experimental Rheumatology|September 17, 2020
Psychosocial burden in young patients with primary anti-phospholipid syndrome: an Italian nationwide survey (The AQUEOUS study)Cecilia Beatrice Chighizola, Francesca Crisafulli, Ariela Hoxha, et al.
Rheumatology (Oxford, England)|June 13, 2026
Prevalence and prognostic value of activated protein C resistance and anti-protein C antibodies in patients with antiphospholipid antibodies: an APS ACTION Registry studyIbrahim Tohidi-Esfahani, Veronica Venturelli, Maria Tektonidou, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|January 27, 2023
Fluctuation of Anti-Domain 1 and Anti-β<sub>2</sub> -Glycoprotein I Antibody Titers Over Time in Patients With Persistently Positive Antiphospholipid AntibodiesCecilia B Chighizola, Francesca Pregnolato, Danieli Andrade, et al.
Pageof 12